US3666767A
(en)
|
1970-01-28 |
1972-05-30 |
Warner Lambert Co |
2-amino-1-(2-imidazolin-2-yl)-2-imidazolines
|
US4863919A
(en)
|
1988-02-01 |
1989-09-05 |
A. H. Robins Company, Incorporated |
Method of enhancing memory or correcting memory deficiency with arylamido(and arylthiomido)-azabicycloalkanes
|
JP3087763B2
(ja)
|
1990-11-30 |
2000-09-11 |
三井化学株式会社 |
新規な複素環式化合物およびそれを含有する医薬組成物
|
TW300219B
(es)
|
1991-09-14 |
1997-03-11 |
Hoechst Ag |
|
JP2553020B2
(ja)
|
1991-11-07 |
1996-11-13 |
吉富製薬株式会社 |
キヌクリジン化合物およびその医薬用途
|
FR2730995B1
(fr)
|
1995-02-23 |
1997-04-04 |
Cird Galderma |
Composes bi-aromatiques derives d'amide, compositions pharmaceutiques et cosmetiques les contenant et utilisations
|
AU727775B2
(en)
|
1996-01-17 |
2000-12-21 |
Novo Nordisk A/S |
Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
|
US6225310B1
(en)
|
1996-01-17 |
2001-05-01 |
Novo Nordisk A/S |
Fused 1,2,4-thiadiazine derivatives, their preparation and use
|
US7214686B2
(en)
|
1997-06-30 |
2007-05-08 |
Targacept, Inc. |
Pharmaceutical compositions and methods for effecting dopamine release
|
US6624173B1
(en)
|
1997-06-30 |
2003-09-23 |
Targacept, Inc. |
Pharmaceutical compositions for treating and/or preventing CNS disorders
|
US6462036B1
(en)
|
1998-11-06 |
2002-10-08 |
Basf Aktiengesellschaft |
Tricyclic pyrazole derivatives
|
US6727070B2
(en)
|
2000-02-14 |
2004-04-27 |
The Board Of Regents, The University Of Texas System |
Protein/solubility folding assessed by structural complementation
|
WO2001066546A1
(fr)
|
2000-03-09 |
2001-09-13 |
Mitsubishi Pharma Corporation |
Composes spiro, leur procede de preparation et leur utilisation comme medicaments
|
WO2002000222A1
(en)
|
2000-06-26 |
2002-01-03 |
Novo Nordisk A/S |
Use of potassium channel agonists for the treatment of cancer
|
AR036041A1
(es)
|
2001-06-12 |
2004-08-04 |
Upjohn Co |
Compuestos aromaticos heterociclicos sustituidos con quinuclidina y composiciones farmaceuticas que los contienen
|
IL160884A0
(en)
|
2001-10-02 |
2004-08-31 |
Upjohn Co |
Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
|
EP1453792B1
(en)
|
2001-11-19 |
2007-04-18 |
Elan Pharmaceuticals, Inc. |
Amine 1,2- and 1,3-diol compounds and their use for treatment of alzheimer's disease
|
US20030125323A1
(en)
|
2001-11-30 |
2003-07-03 |
Jeppe Sturis |
Use of selective potassium channel openers
|
US20030109519A1
(en)
|
2001-11-30 |
2003-06-12 |
Jeppe Sturis |
Use of selective potassium channel openers
|
US20040192594A1
(en)
|
2002-01-28 |
2004-09-30 |
Paul Reid |
Modified neurotoxins as therapeutic agents for the treatment of diseases and methods of making
|
JP2003267977A
(ja)
|
2002-03-14 |
2003-09-25 |
Yamanouchi Pharmaceut Co Ltd |
キヌクリジン誘導体
|
US8299108B2
(en)
|
2002-03-29 |
2012-10-30 |
Novartis Ag |
Substituted benzazoles and methods of their use as inhibitors of raf kinase
|
SI1499311T1
(sl)
|
2002-03-29 |
2010-03-31 |
Novartis Vaccines & Diagnostic |
Substituirani benzazoli in njihova uporaba kot inhibitorji Raf kinaze
|
US20030235583A1
(en)
|
2002-06-14 |
2003-12-25 |
Jeppe Sturis |
Combined use of a modulator of CD3 and a beta cell resting compound
|
EP1530467A2
(en)
|
2002-07-17 |
2005-05-18 |
Warner-Lambert Company LLC |
Combination of an allosteric carboxylic inhibitor of matrix metalloproteinase-13 with celecoxib or valdecoxib
|
DE10234424A1
(de)
*
|
2002-07-29 |
2004-02-12 |
Bayer Ag |
Benzothiophen-, Benzofuran- und Indolharnstoffe
|
AU2003253686A1
(en)
|
2002-08-01 |
2004-02-23 |
Pharmacia & Upjohn Company Llc |
1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity
|
AU2003253186A1
(en)
|
2002-08-13 |
2004-02-25 |
Warner-Lambert Company Llc |
Fused tetrahydropyridine derivatives as matrix metalloproteinase inhibitors
|
BR0313460A
(pt)
|
2002-08-13 |
2005-07-05 |
Warner Lambert Co |
Derivados de naftaleno como inibidores de metaloproteinase da matriz
|
ATE384720T1
(de)
|
2002-08-14 |
2008-02-15 |
Neurosearch As |
Chinucledin - derivate und deren verwendung
|
CN1678589A
(zh)
|
2002-09-05 |
2005-10-05 |
安万特医药股份有限公司 |
作为药物的新氨基吲唑衍生物与含有它们的药物组合物
|
WO2004039366A1
(en)
|
2002-11-01 |
2004-05-13 |
Pharmacia & Upjohn Company Llc |
Nicotinic acetylcholine agonists in the treatment of glaucoma and retinal neuropathy
|
MXPA05004723A
(es)
|
2002-11-01 |
2005-12-05 |
Pharmacia & Upjohn Co Llc |
Compuestos que tienen ambas actividades del agonista alfa 7 nachr y el antagonista 5ht para el tratamiento de las enfermedades del snc.
|
MXPA05005554A
(es)
|
2002-12-12 |
2005-07-26 |
Aventis Pharma Sa |
Derivados de aminoindazol y su utilizacion como inhibidores de quinasas.
|
JP4716517B2
(ja)
|
2003-06-09 |
2011-07-06 |
アルナイラム ファーマシューティカルズ, インコーポレイテッド |
神経変性疾患を治療する方法
|
WO2005016923A1
(en)
|
2003-08-13 |
2005-02-24 |
Neurosearch A/S |
Novel quinuclidine derivatives and their pharmaceutical use
|
PL1682126T3
(pl)
|
2003-10-16 |
2009-12-31 |
Novartis Vaccines & Diagnostics Inc |
Podstawione benzazole i ich zastosowanie jako inhibitorów kinazy Raf
|
US7241773B2
(en)
|
2003-12-22 |
2007-07-10 |
Abbott Laboratories |
3-quinuclidinyl heteroatom bridged biaryl derivatives
|
ATE437880T1
(de)
|
2004-02-04 |
2009-08-15 |
Neurosearch As |
Dimere azacyclische verbindungen und deren verwendung
|
US20050239853A1
(en)
|
2004-02-04 |
2005-10-27 |
Tjeerd Barf |
New compounds
|
EP2336128A1
(en)
|
2004-03-25 |
2011-06-22 |
Memory Pharmaceuticals Corporation |
Benzoisothiazoles and preparation and uses thereof
|
ATE487716T1
(de)
*
|
2004-04-22 |
2010-11-15 |
Memory Pharm Corp |
Indole, 1h-indazole, 1,2-benzisoxazole, 1,2- benzoisothiazole, deren herstellung und verwendungen
|
ES2356251T3
(es)
*
|
2004-04-22 |
2011-04-06 |
Memory Pharmaceuticals Corporation |
Indoles, 1h-indazoles, 1,2-bencisoxazoles, 1,2-bencisotiazoles y preparación y usos de los mismos.
|
WO2005111033A2
(en)
|
2004-05-19 |
2005-11-24 |
Neurosearch A/S |
Novel azabicyclic aryl derivatives
|
EA014419B1
(ru)
|
2004-05-24 |
2010-12-30 |
Эмджен Инк. |
5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения
|
US8686011B2
(en)
|
2004-05-24 |
2014-04-01 |
Amgen Inc. |
Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
|
AU2005293510A1
(en)
|
2004-10-15 |
2006-04-20 |
Neurosearch A/S |
Novel azabicyclic aryl derivatives and their medical use
|
KR20070087674A
(ko)
*
|
2004-12-22 |
2007-08-28 |
메모리 파마슈티칼스 코포레이션 |
니코틴 α-7 수용체 리간드 및 이의 제조 및 용도
|
US20070082350A1
(en)
|
2005-02-09 |
2007-04-12 |
Philip Landfield |
Assay and method for diagnosing and treating alzheimer's disease
|
DE102005038947A1
(de)
|
2005-05-18 |
2006-11-30 |
Grünenthal GmbH |
Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
|
US7580791B2
(en)
*
|
2005-08-10 |
2009-08-25 |
Rm Acquisition, Llc |
Route evaluation system
|
RU2450003C2
(ru)
*
|
2005-09-23 |
2012-05-10 |
Мемори Фармасьютиклз Корпорейшн |
Индазолы, бензотиазолы, бензоизотиазолы, бензоизоксазолы, пиразолопиридины, изотиазолопиридины, их получение и их применение
|
US8106066B2
(en)
|
2005-09-23 |
2012-01-31 |
Memory Pharmaceuticals Corporation |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
|
US7897766B2
(en)
|
2005-09-23 |
2011-03-01 |
Abbott Laboratories |
Amino-aza-adamantane derivatives and methods of use
|
GB0521508D0
(en)
|
2005-10-21 |
2005-11-30 |
Novartis Ag |
Organic compounds
|
US7371862B2
(en)
|
2005-11-11 |
2008-05-13 |
Pfizer Italia S.R.L. |
Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
PE20100743A1
(es)
|
2005-11-15 |
2010-11-25 |
Glaxo Group Ltd |
Nuevos procedimientos y formulaciones
|
US8541592B2
(en)
|
2005-11-22 |
2013-09-24 |
Amgen Inc. |
Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
|
TW200734338A
(en)
|
2006-01-16 |
2007-09-16 |
Organon Nv |
6-Phenyl-1H-imidazo [4,5-c] pyridine-4-carbonitrile derivatives
|
US7687515B2
(en)
|
2006-01-17 |
2010-03-30 |
N.V. Organon |
6-phenyl-1H-imidazo[4,5-c]pyridine-4-carbonitrile derivatives
|
NZ573735A
(en)
|
2006-05-19 |
2011-10-28 |
Abbott Lab |
Cns active fused bicycloheterocycle substituted azabicyclic alkane derivatives
|
EP2038278A2
(en)
|
2006-06-27 |
2009-03-25 |
Abbott Laboratories |
Thiazoline and oxazoline derivatives and their methods of use
|
MX2008016338A
(es)
|
2006-06-27 |
2009-01-16 |
Abbott Lab |
Derivados de pirrol y sus metodos de uso.
|
ITMI20061279A1
(it)
|
2006-06-30 |
2008-01-01 |
Consiglio Nazionale Ricerche |
Agonisti nicotinici selettivi per il sottotipo recettoriale alfa7,procedimento per la loro preparazione e relative composizioni farmaceutiche
|
US8314119B2
(en)
|
2006-11-06 |
2012-11-20 |
Abbvie Inc. |
Azaadamantane derivatives and methods of use
|
US8076350B2
(en)
|
2006-12-22 |
2011-12-13 |
Abbott Laboratories |
Spirocyclic azaadamantane derivatives and methods of use
|
CL2008000597A1
(es)
|
2007-03-01 |
2008-09-05 |
Glaxo Group Ltd |
Forma de dosificacion que comprende 6-(3-ciclobutil-2,3,4,5-tetrahidro-1h-benzo[d]azepin-7-il oxi)-n-metil nicotinamida, un estabilizante y un excipiente; procedimiento de preparacion; y su uso para tratar enfermedades neurologicas.
|
CL2008000596A1
(es)
|
2007-03-01 |
2008-09-05 |
Glaxo Group Ltd |
Forma de dosificacion que comprende 1-(6-[(3-ciclobutil-2,3,4,5-tetrahidro-1h-3-benzazepin-7-il)oxi]-3-piridinil)-2-pirrolidinona, un estabilizador, un excipiente; procedimiento de preparacion; y su uso para tratar enfermedades neurologicas.
|
ES2391596T3
(es)
|
2007-03-23 |
2012-11-28 |
Abbott Laboratories |
Derivados de azaadamantano 4-sustituidos y métodos de uso de los mismos
|
MX2009010174A
(es)
|
2007-03-23 |
2009-10-12 |
Abbott Lab |
Derivados de aza-adamantano ester y carbamato y metodos de uso de los mismos.
|
WO2008118747A1
(en)
|
2007-03-23 |
2008-10-02 |
Abbott Laboratories |
Amimomethyl azaadamantane derivatives and use thereof as selective modulators of the alpha7- neuronal nicotinic acetylcholine receptor (nnrs)
|
JP5364878B2
(ja)
|
2007-03-23 |
2013-12-11 |
アッヴィ・インコーポレイテッド |
アザアダマンタンのアセトアミドおよびカルボキサミド誘導体ならびにそれらの使用方法
|
WO2009017454A1
(en)
|
2007-07-30 |
2009-02-05 |
Astrazeneca Ab |
New therapeutic combination of a gsk3 inhibitor and an a7-nicotinic agonist 960
|
ATE554081T1
(de)
|
2007-09-06 |
2012-05-15 |
Glaxo Group Ltd |
Piperazinderivate mit affinität zum histamin-h3- rezeptor
|
WO2009047255A1
(en)
|
2007-10-09 |
2009-04-16 |
Ucb Pharma, S.A. |
Heterobicyclic compounds as histamine h4-receptor antagonists
|
US20090099099A1
(en)
|
2007-10-16 |
2009-04-16 |
Hong Wang |
Isoflavone Glycosides as Peroxisome Proliferator-Activated Receptor-alpha Modulator
|
GB0720444D0
(en)
|
2007-10-18 |
2007-11-28 |
Glaxo Group Ltd |
Novel compounds
|
US20090197860A1
(en)
|
2007-11-21 |
2009-08-06 |
Abbott Laboratories |
Biaryl substituted diazabicycloalkane derivatives
|
RU2010125121A
(ru)
|
2007-11-21 |
2011-12-27 |
Эббот Лэборетриз (Us) |
Биарилзамещенные производные азабициклических алканов
|
WO2009068617A1
(en)
|
2007-11-30 |
2009-06-04 |
Boehringer Ingelheim International Gmbh |
1, 5-dihydro-pyrazolo (3, 4-d) pyrimidin-4-one derivatives and their use as pde9a modulators for the teatment of cns disorders
|
US8383657B2
(en)
|
2007-12-21 |
2013-02-26 |
Abbott Laboratories |
Thiazolylidine urea and amide derivatives and methods of use thereof
|
GB0800035D0
(en)
|
2008-01-02 |
2008-02-13 |
Glaxo Group Ltd |
Compounds
|
JP2011511800A
(ja)
|
2008-02-07 |
2011-04-14 |
アボット・ラボラトリーズ |
正のアロステリックな修飾物質としてのアミド誘導体およびこれらの使用方法
|
US7786171B2
(en)
|
2008-04-04 |
2010-08-31 |
Abbott Laboratories |
Amide derivatives as positive allosteric modulators and methods of use thereof
|
US8309577B2
(en)
|
2008-04-23 |
2012-11-13 |
Bristol-Myers Squibb Company |
Quinuclidine compounds as α-7 nicotinic acetylcholine receptor ligands
|
WO2009137492A1
(en)
|
2008-05-05 |
2009-11-12 |
Abbott Laboratories |
Heteroaryl-fused macrocyclic pyrimidine derivatives
|
EP2328587A1
(en)
|
2008-08-29 |
2011-06-08 |
Glaxo Group Limited |
Dosage form comprising 1-isopropyl-4-{ [4-(tetrahydro-2h-pyran- 4-yloxy)phenyl]carbonyl}hexahydro-1h-1,4-diazepine or a salt thereof
|
CN102209540A
(zh)
|
2008-11-11 |
2011-10-05 |
塔加西普特公司 |
使用α7-选择性配体的治疗方法
|
RU2015110025A
(ru)
|
2009-06-19 |
2015-08-20 |
Эббви Инк. |
Производные диазагомоадамантана и способы их применения
|
GB0912777D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydropyrimidone derivatives
|
GB0912778D0
(en)
|
2009-07-22 |
2009-08-26 |
Eisai London Res Lab Ltd |
Fused aminodihydro-oxazine derivatives
|
TWI558398B
(zh)
|
2009-09-22 |
2016-11-21 |
諾華公司 |
菸鹼乙醯膽鹼受體α7活化劑之用途
|
MX2012003778A
(es)
|
2009-09-29 |
2012-06-01 |
Glaxo Group Ltd |
Compuestos novedosos.
|
AU2010305825A1
(en)
|
2009-10-13 |
2012-04-19 |
Merck Sharp & Dohme B.V. |
Condensed azine - derivatives for the treatment of diseases related to the acetylcholine receptor
|
US8507516B2
(en)
|
2009-10-28 |
2013-08-13 |
Bristol-Myers Squibb Company |
Azabicyclic compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
US8278320B2
(en)
|
2009-10-28 |
2012-10-02 |
Bristol-Myers Squibb Company |
Azabicyclo[2.2.1]heptane compounds as alpha-7 nicotinic acetylcholine receptor ligands
|
CN102834392A
(zh)
|
2010-02-17 |
2012-12-19 |
詹森药业有限公司 |
作为雌激素相关受体-α调节剂的氨基噻唑酮
|
EP2536283B8
(en)
|
2010-02-18 |
2015-11-04 |
vTv Therapeutics LLC |
Phenyl-heteroaryl derivatives and methods of use thereof
|
GB201004179D0
(en)
|
2010-03-12 |
2010-04-28 |
Pulmagen Therapeutics Inflamma |
Enzyme inhibitors
|
CN103025744A
(zh)
|
2010-04-30 |
2013-04-03 |
百时美施贵宝公司 |
作为α-7烟碱乙酰胆碱受体配体前药的氮杂二环胺N-氧化物化合物
|
AR082827A1
(es)
|
2010-09-02 |
2013-01-09 |
Glaxo Group Ltd |
Compuestos de aril-metiloxi-benzamida, composicion farmaceutica que lo comprende y su uso para la fabricacion de un medicamento util para el tratamiento o la profilaxis de la enfermedad de parkinson
|
US9464078B2
(en)
|
2010-09-23 |
2016-10-11 |
Abbvie Inc. |
Monohydrate of azaadamantane derivatives
|
FR2966827B1
(fr)
|
2010-10-27 |
2014-08-22 |
Kimonella Ventures Ltd |
Compose peptidique utile pour l'inhibition de la formation de plaques amyloides
|
WO2012074799A1
(en)
|
2010-11-18 |
2012-06-07 |
Envivo Pharmaceuticals, Inc. |
Treatment of inflammation with certain alpha-7 nicotinic acid receptor agonists in combination with acetylcholinesterase inhibitors
|
CA2825519A1
(en)
|
2011-02-03 |
2012-09-08 |
Lupin Limited |
Pyrrole derivatives used as modulators of alpha7 nachr
|
JP2014076948A
(ja)
|
2011-02-09 |
2014-05-01 |
Astellas Pharma Inc |
イソキノリンアミド誘導体
|
DK2678327T3
(en)
|
2011-02-23 |
2016-12-12 |
Lupin Ltd |
Heteroaryl derivatives which ALFA7 nAChR modulators
|
KR20140025395A
(ko)
|
2011-03-31 |
2014-03-04 |
루핀 리미티드 |
알츠하이머병 및 파킨슨병을 포함하는 신경병성 장애 치료용 니코틴성 아세틸콜린 수용체 조절인자로서의 피롤 유도체
|
US8946432B2
(en)
|
2011-07-05 |
2015-02-03 |
Lupin Limited |
Biaryl derivatives as nAChR modulators
|
NZ629453A
(en)
|
2012-03-06 |
2016-04-29 |
Lupin Ltd |
Thiazole derivatives as alpha 7 nachr modulators
|
EP2852439A1
(en)
|
2012-05-23 |
2015-04-01 |
Stemergie Biotechnology SA |
Inhibitors of the activity of complex (iii) of the mitochondrial electron transport chain and use thereof
|
EP2855471B1
(en)
|
2012-05-24 |
2017-11-15 |
Bristol-Myers Squibb Company |
QUINUCLIDINE, 1-AZABICYCLO[2.2.1]HEPTANE, 1-AZABICYCLO [3.2.1]OCTANE, and 1-AZABICYCLO[3.2.2]NONANE COMPOUNDS AS ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
|
JOP20130213B1
(ar)
|
2012-07-17 |
2021-08-17 |
Takeda Pharmaceuticals Co |
معارضات لمستقبلht3-5
|
US20150299178A1
(en)
|
2012-11-12 |
2015-10-22 |
Lupin Limited |
Thiazole Derivatives as Alpha 7 NACHR Modulators
|
WO2014083003A1
(en)
|
2012-11-27 |
2014-06-05 |
Shire International Gmbh |
Pro-cognitive compound
|
JP6114951B2
(ja)
|
2012-12-11 |
2017-04-19 |
ノバルティス アーゲー |
アルファ7ニコチン性アセチルコリン受容体アクチベーターによる処置に対する応答性を予測するバイオマーカー
|
US9617211B2
(en)
|
2013-01-16 |
2017-04-11 |
Lupin Limited |
Pyrrole derivatives as alpha 7 nAChR modulators
|
ES2723876T3
(es)
|
2013-02-27 |
2019-09-03 |
Mochida Pharm Co Ltd |
Nuevos derivados de pirazol
|
JP2016512225A
(ja)
|
2013-03-13 |
2016-04-25 |
ルピン・リミテッドLupin Limited |
アルファー7nachrモジュレータとしてのピロール誘導体
|
TW201446243A
(zh)
|
2013-06-03 |
2014-12-16 |
Lupin Ltd |
4-(5-(4-氯苯基)-2-(2-環丙基乙醯基)-1,4-二甲基-1氫-吡咯-3-基)苯磺醯胺作為α7尼古丁乙醯膽鹼受體調節劑
|
CA2913987A1
(en)
|
2013-06-17 |
2014-12-24 |
Lupin Limited |
Pyrrole derivatives as alpha 7 nachr modulators
|
WO2015066371A1
(en)
|
2013-10-31 |
2015-05-07 |
Forum Pharmaceuticals, Inc. |
SPIRO-OXADIAZOLINE COMPOUNDS AS AGONISTS OF α-7-NICOTINIC ACETYLCHOLINE RECEPTORS
|
WO2016100184A1
(en)
|
2014-12-16 |
2016-06-23 |
Forum Pharmaceuticals, Inc. |
Geminal substituted quinuclidine amide compounds as agonists of alpha-7 nicotinic acetylcholine receptors
|
WO2017027600A1
(en)
*
|
2015-08-12 |
2017-02-16 |
Forum Pharmaceuticals, Inc. |
GEMINAL SUBSTITUTED AMINOBENZISOXAZOLE COMPOUNDS AS AGONISTS OF α7-NICOTINIC ACETYLCHOLINE RECEPTORS
|